期刊文献+

血清NSE、CA15-3和CEA在肺癌中表达的临床意义 被引量:3

The clinical significance of serum NSE,CA15-3,CEA in for the diagnosis of lung cnacer
下载PDF
导出
摘要 目的分析血清N SE、CA 15-3和CEA在不同组织类型肺癌中的表达差异。方法对21例肺部良性疾病患者和73例肺癌患者进行血清N SE、CA 15-3和CEA的检测,并分析在肺部良性疾病患者、鳞癌、腺癌和小细胞肺癌患者之间的差别。结果N SE在小细胞肺癌患者中表达水平较高,与肺部良性疾病患者、鳞癌、腺癌患者有显著性差异,CA 15-3及CEA在肺腺癌患者中表达水平较高,与肺部良性疾病患者、鳞癌组有显著性差异,且CA 15-3在诊断肺腺癌的敏感度高于CEA,但N SE、CA 15-3、CEA对肺鳞癌的诊断价值均不大。结论N SE、CA 15-3和CEA在肺癌中的表达与肺癌的组织类型密切相关。 Objective To investigate the expression difference of serum NSE, CA15-3 and CEA for hung cancer, Methods 21 patients with lung benign diseases and 73 patients with lung cancers were included in this retrospecive study. The serum level of NSE, CA15-3 and CEA were measured in lung benign diseases and adenoearcinomas, squamous cell carcinomas, small cell lung cancer. Results The expression of serum NSE was the highest in small cell lung cancer and was significantly higher than in adenocarcinomas, squamous cell carcinomas and lung benign diseases. The expressions of serum CA15-3 and CEA were the highest in adenocarcinomas and were significantly higher than in squamous cell carcinomas and lung benign diseases. The adenocareinomas diagnostic sensibility of serum CA15-3 was higher than CEA, but it had little diagnostic value in squamous cell carcinomas. Conclusion The expression of serum NSF, CA15-3 and CEA is closely connected with the histoloty type of lung cancer.
出处 《东南国防医药》 2006年第1期23-24,共2页 Military Medical Journal of Southeast China
关键词 NSE CA15-3 CEA 肺癌 组织类型 NSE CA15-3 CEA Lung cancer Histology type
  • 相关文献

参考文献6

二级参考文献18

  • 1刘明.一种新的肿瘤标志物:Cyfra21-1[J].国外医学(放射医学核医学分册),1995,19(2):69-70. 被引量:8
  • 2王自正,陆雪龙,付雷,宋庆芳,陶惠云.非小细胞肺癌标志物CYFRA21-1的临床研究[J].中华核医学杂志,1996,16(3):200-201. 被引量:9
  • 3万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 4孙玉萍 申红 等.血清肿瘤标志物CA153在乳腺癌治疗中的应用[J].标记免疫分析与临床,1998,5(2):105-106. 被引量:8
  • 5武洪友 王允惠.在肺癌诊治中的几种标志物 [J].中国实验临床免疫学杂志,1997,9(2):64-64. 被引量:3
  • 6Laberge F, Fritsche HA, Umsawasdi T, et al. Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1[J]. Cancer, 1987,59(12):2047~2052. 被引量:1
  • 7Wieskopf B, Demangeat C, Purohit A, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity,specificity,and prognostic role[J]. Chest, 1995, 108 (1): 163~169. 被引量:1
  • 8Foa P, Fornier M, Miceli R, et al. Tumour markers CEA, NSE, SCC,TPA and CYFRA21-1 in respectable non-small cell lung cancer[J]. Anticancer Res, 1999, 19(4C):3613~3618. 被引量:1
  • 9Vinolas N, Galan MC, Casas F, et al. Tumor markers in response monitoring and prognosis of non-small cell lung cancer. Preliminary report[J]. Anticancer Res, 1998, 18 (1/B): 631~634. 被引量:1
  • 10Pujol JL. Serum Frugment of oytokeration measured by CYFRA21-1 immunoradiometric assay as a marker of lung[J].Cancer Research,1993,53(6):66. 被引量:1

共引文献246

同被引文献16

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部